ReAlta Life Sciences

ReAlta is a clinical-stage biotech company that develops a new class of drugs to address life-threatening diseases.

ReAlta Life Sciences is active in the biotechnology, life science, pharmaceutical space based in East Coast, Southern US, founded in 2018.

Within the biotechnology, life science, pharmaceutical space, the company focuses on its core offering rather than a broad product line.

East Coast, Southern US is where the company is located.

Its current recorded stage is Grant.

The company reports a headcount in the c_00011_00050 range.

Total disclosed funding stands at about $53.2M.

Website: realtalifesciences.com